Sofosbuvir plus Daclatasvir without Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Decompensated Liver Disease: Response of sofosbuvir plus daclatasvir in decompensated cirrhosis. Journal of Fatima Jinnah Medical University, v. 14, n. 1, p. 41–44, 13 Jul.2020.